Search research articles
Contact Us
Filters
Showing results (71-80 of 141) with videos related to
Page
of 15
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
July 7, 2025
Prognostic Value of a Joint K-PD Model With Tumor Size Dynamics and CA-125 Kinetics in Recurrent Ovarian Cancer Patients: BOLD Phase II GINECO Study
Aurore Carrot, Pauline Corbaux, Olivier Colomban, et al.
Cancer Chemotherapy and Pharmacology
|
June 6, 2020
Validation of an online tool for early prediction of the failure-risk in gestational trophoblastic neoplasia patients treated with methotrexate
Kathleen Dekeister, Pierre-Adrien Bolze, Michel Tod, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
Molecular Analyses of Chorionic-Type Intermediate Trophoblastic Lesions: Atypical Placental Site Nodules are Closer to Placental Site Nodules Than Epithelioid Trophoblastic Tumors
Gaspard Jeremie, Fabienne Allias, Alexis Trecourt, et al.
Biomedicines
|
October 23, 2021
Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma
Constance Collet, Jonathan Lopez, Christophe Battail, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2019
Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study
Olivier Colomban, Michel Tod, Alexandra Leary, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
January 31, 2024
Retrospective analysis of uterine involvement in low grade serous ovarian carcinoma
Florian Petiot, Pierre Descargues, Mojgan Devouassoux-Shisheboran, et al.
Gynecologic Oncology
|
May 23, 2013
The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: data from CALYPSO trial (a GINECO-GCIG study)
Benoit You, Olivier Colomban, Mark Heywood, et al.
Nature Communications
|
February 20, 2025
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial
Max Piffoux, Alexandra Leary, Philippe Follana, et al.
The Oncologist
|
September 14, 2024
Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program
Claire Lattard, Chloé Herledan, Thibaut Reverdy, et al.
Future Oncology (London, England)
|
May 13, 2015
Multiparameter Phase I trials: a tool for model-based development of targeted agent combinations--example of EVESOR trial
Mevidette El-Madani, Emilie Hénin, Thibaud Lefort, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 141) with videos related to
Sort By:
Page
of 15
CPT: Pharmacometrics & Systems Pharmacology
|
July 7, 2025
Prognostic Value of a Joint K-PD Model With Tumor Size Dynamics and CA-125 Kinetics in Recurrent Ovarian Cancer Patients: BOLD Phase II GINECO Study
Aurore Carrot, Pauline Corbaux, Olivier Colomban, et al.
Cancer Chemotherapy and Pharmacology
|
June 6, 2020
Validation of an online tool for early prediction of the failure-risk in gestational trophoblastic neoplasia patients treated with methotrexate
Kathleen Dekeister, Pierre-Adrien Bolze, Michel Tod, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
Molecular Analyses of Chorionic-Type Intermediate Trophoblastic Lesions: Atypical Placental Site Nodules are Closer to Placental Site Nodules Than Epithelioid Trophoblastic Tumors
Gaspard Jeremie, Fabienne Allias, Alexis Trecourt, et al.
Biomedicines
|
October 23, 2021
Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma
Constance Collet, Jonathan Lopez, Christophe Battail, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2019
Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study
Olivier Colomban, Michel Tod, Alexandra Leary, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
January 31, 2024
Retrospective analysis of uterine involvement in low grade serous ovarian carcinoma
Florian Petiot, Pierre Descargues, Mojgan Devouassoux-Shisheboran, et al.
Gynecologic Oncology
|
May 23, 2013
The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: data from CALYPSO trial (a GINECO-GCIG study)
Benoit You, Olivier Colomban, Mark Heywood, et al.
Nature Communications
|
February 20, 2025
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial
Max Piffoux, Alexandra Leary, Philippe Follana, et al.
The Oncologist
|
September 14, 2024
Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program
Claire Lattard, Chloé Herledan, Thibaut Reverdy, et al.
Future Oncology (London, England)
|
May 13, 2015
Multiparameter Phase I trials: a tool for model-based development of targeted agent combinations--example of EVESOR trial
Mevidette El-Madani, Emilie Hénin, Thibaud Lefort, et al.
Page
of 15